Sresta Natural Bioproducts IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 17, 2022One of the largest brands proffering organic food and ingredients has filed the preliminary documents with SEBI for launching its IPO.
And here’s everything you need to know to understand Sresta Natural Bioproducts IPO. We have set forth all the details you are searching for.
In the article, you find details about the emergence and history of the company. Its products and services, promoters, management, financial statements. In regards to the IPO, we have covered details of IPO date, Subscription status, allotment status, GMP, and much more.
Also, with this Sresta Natural Bioproducts IPO Review, you will be able to decide whether the IPO is prosperous or not.
| Face Value | Rs 10 |
| Price Band | Not Disclosed |
| Listing At | BSE, NSE |
| Min. Order Quantity | Not Disclosed |
| Listing Date | Not Disclosed |
| Offer for Sale | Not Disclosed |
| Fresh Issue | Rs.50 Crore |
| IPO Size | Rs.500 Crore |
| Tick Size | 1 |
Sresta Natural Bioproducts IPO Overview
Hyderabad-based company, Sresta Natural Bioproducts Ltd engaged in the business of providing packaged organic food is gearing up to garner funds of about Rs. 500 crore from the General Public with the upcoming IPO.
The Sresta Natural Bioproducts IPO comprises of a fresh issue of equity shares worth Rs. 50 crore and an Offer for Sale of upto 70.30 lakhs equity shares by the existing shareholders.
The company happens to one of the pioneers in the industry of offering packaged organic food. The aim of the company is to provide food which is safe from the chemicals and pesticides and to offer the richness and goodness of wholesome nature food products.
Sresta Natural Bioproducts IPO Important Dates
| Events | Date |
| IPO Opening Date | Not Disclosed |
| IPO Closing Date | Not Disclosed |
| Basis of Allotment Finalization | Not Disclosed |
| Refunds Initiation | Not Disclosed |
| Credit of Shares to Demat Account | Not Disclosed |
| Share Listing Date | Not Disclosed |
In the month of January 2022, Sresta Natural Bioproducts Ltd filed the DRHP with SEBI for seeking its approval for the IPO.
In pursuance of the IPO, the company was converted from a private limited company to a public limited company to effect the proposed IPO in December 2021 and subsequently the name of the company was also changed to Sresta Natural Bioproducts Ltd.
Now, the company is eyeing on receiving SEBI nod and to proceed with the launch of IPO. Sresta Natural Bioproducts IPO Date will be made available after the approval.
Sresta Natural Bioproducts IPO Price, Size, Share Offerings
| Face Value | Rs.10 |
| Price Band | Not Disclosed |
| Offer for Sale | Not Disclosed |
| Fresh Issue | Rs.50 Crore |
| IPO Size | Rs.500 Crore |
As mentioned in the DRHP, Sresta Natural Bioproducts IPO Size is of about Rs.500 crore where Rs. 50 crore will be raised by way of a fresh issue and further sum with an offer for sale of 70,30,962 equity shares.
The face value of the offered shares is Rs. 10 each. The Sresta Natural Bioproducts IPO Price, price band and the minimum lot will be determined by the company in consultation with the Lead Managers and will be published in the newspaper.
Sresta Natural Bioproducts IPO Grey Market Premium
| Date | GMP (Rs.) | Kostak Rate (Rs.) | Subject to Sauda (Rs.) |
| Not Trading in Grey Market yet | |||
Grey Market has always played a vital role in determination and estimating the listing price of an offered share. Investors vest high reliability in the trends of Grey Market in respect of an IPO.
Though, Grey Market is unofficial, it is not regulated by a law, yet trading in the grey market has it significance in the IPO process.
Sresta Natural Bioproducts IPO GMP is not available upto now. We will update you soon in a short time.
Sresta Natural Bioproducts IPO Subscription Status
| Day / Date | QIB | NII | RII | Total Subscription |
| 1st Day – | ||||
| 2nd Day – | ||||
| 3rd Day – | ||||
| Shares Offered or Net Issue |
Sresta Natural Bioproducts IPO Subscription will be done based on the following reservations for the specified category of investors, namely – not less than 75% of the offer will be available for Qualified Institutional Buyers for allocation, not more than 15% of the offer will be allocated to Non-Institutional Buyers and the rest 10% will be available for allocation to Retail Investors.
The bidders will be able to participate in the IPO with the ASBA process. Additionally, Retail investors can also place bids using UPI mechanism.
The Lead Managers of the issue are:
- JM Financial Limited
- Axis Capital Limited
The details in respect of the price band and subscription will be made available in a short time.
Sresta Natural Bioproducts IPO Allotment Status
Sresta Natural Bioproducts IPO Allotment is not determined yet. The basis of allotment will be determined by the company in consultation with the BRLMs subject to the approval of the designated Stock Exchange.
The Book Running Lead Managers of the issue are:
1. JM Financial
2. Axis Capital
Registrar to this issue is KFin Technologies Private Limited.
The equity shares are proposed to be listed on BSE and NSE.
Sresta Natural Bioproducts IPO Live Performance
Investors will be able to check and stay updated with the Sresta Natural Bioproducts IPO Performance just with a single click from the link given below.
Subscribe to Sresta Natural Bioproducts IPO – Open Free Demat Account Now!
Latest Sresta Natural Bioproducts IPO News
Sresta Natural Bioproducts – Company Review
Sresta Natural Bioproducts embarked its remarkable journey as a Private company as Sresta Natural Bioproducts Private Limited in the year 2004. The company’s registered office is located in Hyderabad.
In the year 2021, the company undertook the conversion to a public company.The company offer a wide array of products. The product portfolio comprises of spices, grains, lentils dry fruits, organic teas and more.
The company owns the brand 24 Mantra which has attained a great prominence in the market and is one of the market leaders in India.
24 Mantra is the largest brand in the packaged organic food segment by market share with approximately 29% market share in Fiscal 2020.The company operates not only in India but has marked its footprints globally with a presence in 34 countries.
Products or Services
Sresta Natural Bioproducts, founded by Rajashekar Reddy Seelam is engaged in the business of manufacturing, procuring, marketing, processing, and research & development of organic food products. The aim of the company has always been to offer to the people of India and the world, food products which are free from chemicals and harmful ingredients.
To offer fresh, safe and healthy food items and ensure an healthy environment for all.
While delivering its products and satisfying the goals set forth, the company has become a famous brand in the USA with presence in 39 states and in aggregate it is serving 34 countries all over the globe. It is competing with some of the leading channels in the industry.
Product line of the company includes grocery staples, spices and condiments, edible oils, packaged food, beverages, meal accompaniments, etc.
Promoters and Holding
The Promoter of Sresta Natural Bioproducts are:
1. Rajashekar Reddy Seelam
2. Renuka Seelam
3. Balasubramanian NarayananThe three promoters holds 23.63% stakes in the company together.
The three promoters holds 23.63% stakes in the company together.
The management of the company comprises of:
1. Pradeep Narendra Poddar holds the position of Chairman and Independent Director
2. Rajashekar Reddy Seelam holds the position of Managing Director
3. Balasubramanian Narayanan holds the position of Whole-time Director and Chief Executive Officer
4. Pranav Kumar Suresh holds the position of Nominee Director
5. Ramesh Alur holds the position of Nominee Director
6. Venkatesan Karaiyalan holds the position of Chief Financial Officer.
Is Sresta Natural Bioproducts good for Investment?
Sresta Natural Bioproducts started in 2004 has achieved the position of largest brand with 24 Mantra. The company maintains high quality and prompt of goods to its customers. The products of the company are high in demand and has become preference for many.
The operations of the company are not confined to the national boundaries and has outspread its reach internationally.
The Hyderabad based company is backed by private equity firm Peepul Capital and venture capital firm VenturEast.
The management of the company has highly experienced individuals who are taking the company to newer heights with its unstoppable endeavors.
Sresta Natural Bioproducts Financial Statements
| Amount (in INR & Million) | |||||
| 30-Sept-21 | 30-Sept-20 | Mar-21 | 31-Mar-20 | 31-Mar-19 | |
| Assets | 2,210.85 | 2,222.35 | 1,935.74 | 1,695.32 | 1,589.28 |
| Revenue | 1,611.24 | 1,565.88 | 3,143.70 | 2,664.24 | 2,082.08 |
| Expense | 1,585.64 | 1,465.27 | 3,006.30 | 2,523.45 | 2,118.83 |
| Profit After Tax | 11.37 | 73.20 | 103.93 | 94.60 | (34.69) |
Sresta Natural Bioproducts is a profit making company with a record of year-on-year profits.
The total revenue for the financial year 2021 of the company was Rs. 3,143.70 million and the profit for the same period was Rs. 137.40 million.
The financials of the company reflects a positive and progressive status of the company.
With diversification in the products, the profits of the company might also rise.
The EPS of the company for 2021 was Rs. 5.69.
| Earnings per Equity Share (in Million) | |||||
| 30-Sept-21 | 30-Sept-20 | Mar-21 | 31-Mar-20 | 31-Mar-19 | |
| Basic | 0.62 | 4.01 | 5.69 | 5.18 | (1.93) |
| Diluted | 0.62 | 4.00 | 5.67 | 5.17 | (1.93) |
Sresta Natural Bioproducts IPO Review
The largest brand of packaged organic food segment has proposed an IPO worth Rs. 500 crore. The IPO is a combination of Fresh Issue and an Offer for Sale by its promoters and existing shareholders.
Started in 2004, the company has witnessed a growing and prosperous journey.
The proceeds from the IPO are proposed to be utilized towards fulfilling working capital requirements and to make payment towards the debts availed by the company.
The company offers great variety of products and its products portfolio is also continuously expanding.
While offering its products, the company is also offering incredible work opportunities to 34,516 farmers.
Sresta Natural Bioproducts IPO Details
Here are few more details you need to know before investing in Sresta Natural Bioproducts IPO –
Sresta Natural Bioproducts IPO Issue Object
Sresta Natural Bioproducts has proposed diverse objectives for making the IPO offer and some of the objectives are:
- Funding the working capital requirements of our Company;
- Repayment or pre-payment in full or part, of certain outstanding unsecured / secured borrowings availed by our Company; and
- General corporate purposes
Sresta Natural Bioproducts IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Market leader and one of the pioneers in the rapidly growing organic foods industry in India with a diversified and innovation driven product portfolio through our research and development efforts;
- Pan-India presence and market leadership fostered by an omni-channel distribution network;
- One of the leading Indian organic food brands in the USA with exports to a total of 34 countries;
- Large scale and efficient sourcing and procurement network, which is an entry barrier, further strengthened through exclusive procurement access to farmers within our network;
- Asset-light model with strategically located processing facilities and end-to end control over the integrated supply chain with a focus on quality; and
- Experienced Promoters and professional management team
Quantitative factors are:
| Basic EPS | Diluted EPS | RONW (%) | NAV (Rs.) | |
| 31-Mar-21 | 5.69 | 5.67 | 13. 61 | 42.33 |
| 31-Mar-20 | 5.18 | 5.17 | 14.22 | – |
| Mar-19 | (1.93) | (1.93) | (6.11) | – |
Sresta Natural Bioproducts IPO Lead Managers
Here are the list of Lead managers –
- JM Financial Limited
- Axis Capital Limited
Sresta Natural Bioproducts IPO Registrar to offer
Check out the details of registrar here –
KFin Technologies Private Limited
Selenium Tower B, Plot No. 31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500 032 Telangana, India
Tel: +91 40 6716 2222
Toll free no.:1800 345 4001
E-mail: sresta.ipo@kfintech.com
Investor grievance e-mail: einward.ris@kfintech.com
Website: www.kfintech.com
Contact person: M Murali Krishna
SEBI registration no.: INR000000221
Sresta Natural Bioproducts IPO – Other Details
- Statutory Auditor – M S K A & Associates
- Legal Counsel to the Company – Shardul Amarchand Mangaldas & Co
- Bankers to the Company – Axis Bank Limited
Sresta Natural Bioproducts IPO Verdict by Stock Brokers
Sresta Natural Bioproducts IPO – Conclusion
Amongst the pioneers and a Market Leader now, Sresta Natural Bioproducts is an innovation driven company with a extensively diversified product portfolio. It puts emphasis on research and development of its products and serve well.
The company delivers its products Pan India and has developed an omnichannel distribution network.
The investment in the company might turn out to be a healthy opportunity for the investors and investors can consider bidding in the IPO.
To Subscribe to Sresta Natural Bioproducts IPO – Open Demat Account Now!
Sresta Natural Bioproducts IPO Review FAQs
Check out the FAQs on Sresta Natural Bioproducts IPO –
What is the Issue Size of Sresta Natural Bioproducts IPO?
The Company is making an initial public offer of NA equity shares. They vividly portray the aspects of the issue in this article.
You can check the stats on the fresh issue, Offer for sale, and net issue.
What is the Price band of Sresta Natural Bioproducts IPO?
The price band for this particular IPO ranges between NA. As far as the face value of the share is of concern, it is Rs.1 per share.
What is the Sresta Natural Bioproducts IPO Open Date?
The opening and closing dates for this IPO have been updated. The IPO is set to open on NA, while the closing date is set at NA.
What is the Sresta IPO Allotment Date?
They also have the news regarding the respective allotment dates of this IPO.
Basis of Allotment finalization is on NA, refund initiation is on NA, credit of shares is on NA, and share listing date is on NA.
What is the Sresta Natural Bioproducts IPO Listing Date?
Shares of this company shall be listed in the exchanges NA. The date, when the listing would be done, is stagnant on NA.
Who is the Registrar of Sresta IPO?
One of the reputed registrars is managing the issue of this IPO, i.e. KFin Technologies Private Limited. Their website will help you regarding the further information you are on the lookout for.
Who is the Promoter of Sresta Natural Bioproducts IPO?
Here are the promoters of this IPO – RAJASHEKAR REDDY SEELAM, RENUKA SEELAM AND BALASUBRAMANIAN NARAYANAN. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
What is the GMP of Sresta Natural Bioproducts IPO?
They have obtained the GMP of this IPO and it is NA. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.
Is Sresta Natural Bioproducts IPO good for Investment?
They have further provided the financial status of the company in this article, from the past few years.
You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
What is the PAT of Sresta Natural Bioproducts Company?
They have the information of company financials, and according to that, they have the figures from the last few years to provide.
PAT for the financial year 2021 in Million is 103.93, 2020 is 94.60, 2019 is (34.69). PAT from Sept 2021 is 11.37.
Featured Topics